| Quality Matters | U.S. Pharmacopeia Blog

Strengthening Global Medicines Quality: USP’s New Role in Harmonization

USP Staff Submitted by USP Staff on Thu, 07/28/2016 - 09:45
Harmonization and Global Medicines Quality

In the past three decades, an increasingly globalized medical marketplace has helped improve patient access to new medicines. Sadly, it has also provided an opportunity for more substandard, adulterated, and counterfeit medical products. This article explains the evolving role of the ICH in helping to tackle this problem through harmonization, and how USP is linked to the effort. 

Pharmaceutical Manufacturing in LMICs: Where Things Go Wrong

Patrick Lukulay Submitted by Patrick Lukulay on Tue, 05/24/2016 - 10:53
Root Causes of Substandard Medicines

In LMICs, the availability of medicines manufactured locally that do not meet quality standards is a leading cause of treatment failure and adverse events in patients and is undermining public health interventions. But where do things go wrong during pharmaceutical manufacturing in LMICs that give rise to this problem? Learn more.